Thank you for registering!
Sign up for our free newsletters to receive the latest LGBTQ news from the Carolinas in your inbox every week.
Your support makes our work possible. Every story we publish, every event we cover, and every community voice we uplift exists because of readers like you. Behind every headline is a story worth telling, and your membership helps keep those stories alive.
Together, we aim to welcome 200 new Press Club members by December 31, 2025, building the foundation for 1,000 members by June 2026. Join the Press Club today and help us reach our goal.
Did you know you can view homepages related to your area? Select a location and bookmark it today.
According to a press release by the Department of Justice, Gilead Sciences, Inc. has infringed upon four U.S. patents in connection with the pharmaceutical company’s Truvada and Descovy, which are marketed to prevent HIV as part of the PrEP regimen.
